Glaucoma Research Foundation is dedicated to finding a cure for glaucoma and restoring vision through research.

Glaucoma Research Foundation

Doheny Eye Institute focuses on the conservation, improvement, and restoration of human eyesight, according to self-described mission.

Doheny Eye Institute

Cambridge Eye Trust is a charity dedicated to supporting and funding eye research programs, education in ophthalmology, and initiatives aimed at improving patient care. self-described.

Cambridge Eye Trust

Glaucoma Research Foundation | 3,404 followers on LinkedIn. Our mission is to cure glaucoma and restore vision through innovative research. | At Glaucoma Research Foundation (GRF), our mission is to cure glaucoma and restore vision through innovative research. For more than 45 years, GRF has worked to advance sight-saving research and provide essential educational resources for patients. We fund critical research into glaucoma treatment, vision restoration, and a cure.

Director of Communications at Glaucoma Research Foundation

Andrew Jackson

Independent Director, Public and Private Biotech/Pharma Companies — Board Chair, RD Fund — Former CEO, Santen Inc — Former Chair, Iveric Bio

Adrienne Graves

Attending Clinician and Surgeon, Glaucoma Associates of Texas

Tosin Smith

Ophthalmologist and Glaucoma Surgeon at Bovee Eye in Tampa Bay

Courtney Bovee, MD

The countdown is on! We are just about one month away from #AAO2024 in #Chicago . Join us along with Iantrek and Inder Singh on Saturday, October 19th, for an extraordinary event at the Adler Planetarium, kicking off at 6:30 PM. We are thrilled to connect with the brightest minds in the ophthalmic community-surgeons, thought leaders, and innovators alike. You won't want to miss this event; it's an evening of Innovation, Awareness, and Celebration! If you are attending the AAO conference in Chicago, drop a comment below, and we'll make sure you get an exclusive invite to our special event! #lantrek #AAO #InterventionalGlaucoma #GlaucomaResearchFoundation #Funkadesi

Please take a few minutes to complete a brief survey to help us improve our activities and services. https://lnkd.in/giJBaWmU Your responses are confidential, unless you choose to provide us with your name and email address so we can follow up with you. We appreciate your input!

We are thrilled to celebrate Alexandra, our dedicated Development Assistant, who recently ran a 10K to raise funds for glaucoma research! Alex is passionate about making a difference in the lives of those affected by glaucoma, and her commitment to our mission truly shines through. "In my role at GRF, I speak with glaucoma patients daily and am constantly inspired by their resilience. I chose to fundraise for GRF because it is an organization dedicated to serving patients by investing in bold ideas and supporting research that would otherwise not be conducted. Knowing that my efforts were helping to advance this research and find a cure for glaucoma kept me motivated during the race. It also felt like a meaningful way to honor all the resilient patients I have come to know during my time with GRF." -Alexandra Dewey Feeling inspired? You can make a difference too! Create your own peer-to-peer fundraiser and help us continue our mission to find a cure for glaucoma. Download our Fundraising Guidebook to get started! https://lnkd.in/gie545Ai

BIG thank you to AbbVie for being a Presenting Sponsor of Glaucoma 360! Your support drives innovation and progress in the fight against glaucoma. Together, we’re making a difference in the lives of patients nationwide. . . . #Glaucoma360 #ThankYou #AbbVie #2025

Exciting breakthroughs are on the horizon! Check out the latest research update from our Catalyst for a Cure teams as they make strides in understanding and treating glaucoma. Read more: 🔗 https://lnkd.in/gYNvErQG *Karthik Shekhar, PhD from UC Berkeley (CFC4) is featured on the cover of this post #GlaucomaResearch #VisionForTheFuture #CatalystForACure

We’re excited to announce that our President and CEO, Thomas M. Brunner will be participating in ‘The Patient Voice & Reaction Panel’ session at the 2024 Focus on Eye Health Summit on July 10th. This year’s event emphasizes the importance of a person-centered approach to vision health interventions, research, communications, and care. For more information visit: https://lnkd.in/dRz3dW8

🗓️ Join us on July 18, 2024, at 12:00 PM PT for our upcoming webinar: "Glaucoma Medications: From Drops to Implants," presented by Arpine Barsegian, MD. Discover the latest advancements in glaucoma treatment and get your questions answered by a leading expert. Don't miss out! 🌟 #Glaucoma #Webinar #EyeHealth #MedicalAdvancements #SaveTheDate 🔗 Register now: https://lnkd.in/gHwSqVjd

A heartfelt thank you to our Platinum Sponsor, Alcon, for their incredible support at the Glaucoma Patient Summit 2024! Your commitment to advancing eye care makes a world of difference. Learn more: www.glaucoma.org/summit See you on June 28th and 29th! 👁️❤️ #GlaucomaSummit2024 #ThankYouAlcon #EyeCareAdvancement

🔬 Exciting breakthrough! Our lead investigator, Dr. Xin Duan, and his team have discovered a new type of neuron that plays a crucial role in forming the intricate vascular networks in the retina. This groundbreaking research could pave the way for innovative therapies for glaucoma and other neurodegenerative diseases. 🌟 Read more about this discovery and its potential impact: https://lnkd.in/erpPr3_P

The Glaucoma Research Foundation's Shaffer Research Grants application is now open! 🌟If you have innovative ideas and a passion for advancing glaucoma research, this is your chance to make a difference. Apply now and join the fight to find a cure. 🚀 https://lnkd.in/gCyUyATx #GlaucomaResearch #ShafferGrants #ApplyNow #VisionForTheFuture

Metric
Company Name	Glaucoma Research Foundation	Doheny Eye Institute	Cambridge Eye Trust
Symbol
MSH ID	ORG:GLAUCOMA	ORG:DOHENY	UK:ORG:CAMBRIDGEEYETRUST
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Nonprofit Healthcare	Medical Research	Non-Profit Organization
Country	US	US	GB
Stage
Employee Count
Website	glaucoma.org	doheny.org	cambridgeeyetrust.org.uk
LinkedIn	glaucoma-research-foundation	doheny-eye-institute	cambridge-eye-trust
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	68.41K	3.63K
Web Traffic Growth	-0.41	0.22
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GLAU

ORG:GLAUCOMA

Glaucoma Research Foundation

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue